NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)
CUSIP: 64125C109
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 99,963,154
- Total 13F shares
- 1,917,771
- Share change
- -443,653
- Total reported value
- $250,907,825
- Price per share
- $131.74
- Number of holders
- 130
- Value change
- -$61,495,089
- Number of buys
- 65
- Number of sells
- 50
Quarterly Holders Quick Answers
What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 64125C109:
Top shareholders of NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
12%
from 13D/G
|
12,830,597
|
$1,819,763,595 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.7%
|
9,700,301
|
$1,375,793,692 | — | 31 Dec 2025 | |
| DODGE & COX |
13F
13D/G
|
Company |
5.6%
from 13D/G
|
5,508,042
|
$781,205,597 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
13D/G
|
Company |
5.2%
from 13D/G
|
5,200,356
|
$737,566,619 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
4.8%
from 13D/G
|
4,242,681
|
$601,739,446 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.3%
|
3,271,706
|
$462,651,883 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.2%
|
2,238,797
|
$317,528,579 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
2,059,282
|
$291,341,652 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.9%
|
1,872,240
|
$265,541,000 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.7%
|
1,744,560
|
$247,430,944 | — | 31 Dec 2025 | |
| Bellevue Group AG |
13F
|
Company |
1.7%
|
1,703,304
|
$241,579,606 | — | 31 Dec 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1.4%
|
1,395,902
|
$197,989,000 | — | 31 Dec 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,291,278
|
$178,248,014 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
1,221,184
|
$173,200,527 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
1,209,378
|
$171,526,511 | — | 31 Dec 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.2%
|
1,184,345
|
$167,975,651 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
1,146,896
|
$162,664,260 | — | 31 Dec 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.1%
|
1,062,072
|
$150,633,672 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.99%
|
984,811
|
$139,675,744 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.98%
|
983,528
|
$139,493,777 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.85%
|
850,632
|
$120,645,137 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.84%
|
842,592
|
$119,504,823 | — | 31 Dec 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.82%
|
820,240
|
$116,334,639 | — | 31 Dec 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.78%
|
776,934
|
$110,304,874 | — | 31 Dec 2025 | |
| BRAIDWELL LP |
13F
|
Company |
0.75%
|
751,534
|
$106,590,067 | — | 31 Dec 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.75%
|
745,113
|
$105,679,358 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.74%
|
738,676
|
$104,766,446 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.72%
|
722,476
|
$102,468,771 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.72%
|
716,475
|
$101,611,949 | — | 31 Dec 2025 | |
| Fiera Capital Corp |
13F
|
Company |
0.64%
|
637,408
|
$90,403,576 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.63%
|
631,422
|
$89,220,928 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.59%
|
585,677
|
$83,066,515 | — | 31 Dec 2025 | |
| Swedbank AB |
13F
|
Company |
0.58%
|
584,129
|
$82,847,016 | — | 31 Dec 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.58%
|
576,648
|
$81,787,000 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.56%
|
555,494
|
$78,785,714 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.53%
|
532,759
|
$75,561,209 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.53%
|
528,104
|
$74,901,036 | — | 31 Dec 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.51%
|
507,740
|
$72,012,765 | — | 31 Dec 2025 | |
| Kevin Charles Gorman |
3/4/5
|
Director |
—
mixed-class rows
|
556,670
mixed-class rows
|
$70,360,582 | -$14,597,492 | 13 Feb 2026 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.49%
|
486,809
|
$69,044,178 | — | 31 Dec 2025 | |
| Zurich Insurance Group Ltd/FI |
13F
|
Company |
0.46%
|
459,437
|
$65,161,950 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.46%
|
459,176
|
$65,127,039 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.44%
|
442,866
|
$62,811,685 | — | 31 Dec 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.39%
|
389,297
|
$55,213,994 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.37%
|
367,944
|
$52,185,497 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.36%
|
364,535
|
$51,701,928 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.36%
|
360,711
|
$51,159,641 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.35%
|
348,843
|
$49,476,400 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.34%
|
343,421
|
$48,707,399 | — | 31 Dec 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.34%
|
339,432
|
$47,724,140 | — | 31 Dec 2025 |
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2026
As of 31 Mar 2026,
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,917,771 shares.
The largest 10 holders included
Pictet Asset Management Holding SA, PKO BP BANKOWY Universal Pension Society JSC, Retirement Systems of Alabama, Assenagon Asset Management S.A., Robeco Institutional Asset Management B.V., WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, SG Americas Securities, LLC, Robinhood Asset Management, LLC, Continuum Advisory, LLC, and OPPENHEIMER & CO INC.
This page lists
130
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
721
Q1 2026 holders
130
Holder diff
-591
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.